Life Science Angels Invests in NeuroHealing Pharmaceuticals. Company is Preparing for Two Phase II Clinical Trials: one to Aid Patients Recovering from Coma and another to Treat Sialorrhea in Parkinson’s Disease

Palo Alto, Calif. and Newton, Mass., April 05, 2006 — PRNewswire Life Science Angels, Inc., a Bay Area healthcare angel investment group focused exclusively on early stage biotechnology and medical device companies, announced today an investment in NeuroHealing Pharmaceuticals, Inc. NeuroHealing Pharmaceuticals is a clinical stage company developing therapies to improve the neuro-rehabilitation process and…